Cargando…
Inhibition of MLKL Attenuates Necroptotic Cell Death in a Murine Cell Model of Hepatic Ischaemia Injury
Background: Steatosis in donor livers poses a major risk of organ dysfunction due to their susceptibility to ischaemia-reperfusion (I/R) injury during transplant. Necroptosis, a novel form of programmed cell death, is orchestrated by receptor-interacting protein kinase 1 (RIPK1), receptor-interactin...
Autores principales: | Baidya, Raji, Gautheron, Jérémie, Crawford, Darrell H. G., Wang, Haolu, Bridle, Kim R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826539/ https://www.ncbi.nlm.nih.gov/pubmed/33435617 http://dx.doi.org/10.3390/jcm10020212 |
Ejemplares similares
-
Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
por: Baidya, Raji, et al.
Publicado: (2020) -
Post-translational control of RIPK3 and MLKL mediated necroptotic cell death
por: Murphy, James M., et al.
Publicado: (2015) -
The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease
por: Tovey Crutchfield, Emma C., et al.
Publicado: (2021) -
HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death
por: Jacobsen, A V, et al.
Publicado: (2016) -
Spatiotemporal control of necroptotic cell death and plasma membrane recruitment using engineered MLKL domains
por: Taslimi, Amir, et al.
Publicado: (2022)